Day 1 – Tuesday 20th MayTuesday, 20 May 2025 - CET (Central European Time, GMT+01:00)

Norway’s life science industry has immense potential to take a leading role on the global arena. This opening keynote session will discuss a roadmap to strengthen Norway’s life science ecosystem through concrete actions and strategic priorities. It will explore how the combined efforts of government, public institutions, companies, and investors could define and realize Norway’s ambition to become a leader in life sciences. We will also explore how we can spearhead the promotion of greater Nordic collaboration (by sharing expertise, resources, and strategic initiatives) to create a unified and competitive regional life science hub.

• Establishing a vision for Norway’s role in the global life science industry, leveraging its strengths while addressing critical gaps
• Identifying areas where Norway excels and focusing efforts on closing gaps in research, innovation, and commercialization to remain competitive internationally
• Discussing how the Nordic countries can capitalize on their collective strengths in research, innovation, and regulatory frameworks to create a globally competitive life science ecosystem
• How can we overcome the challenges and opportunities in fostering seamless cross-border collaboration? (including regulatory harmonization, data sharing, and talent mobility)

Women’s health has been under-prioritized for a long time. It should be no surprise that women are approximately one half of the world’s population. Yet remarkably, only 1% of healthcare research and innovation is invested in specific female conditions outside oncology. As well as the general lack of knowledge, focus, research funds, entrepreneurs/start-ups, and investors within the entire area. However, there are many initiatives in the Nordics that are encouraging knowledge sharing and facilitating discussions around this important topic. Sweden and Denmark are already global frontrunners within infertility and reproduction.

Join this panel discussion as we showcase how the Nordic region is tackling this important issue and highlight the progress being made in the space. · What progress has been made and what are the persisting gaps/challenges in care, research, and investment?

• Highlighting successful initiatives, innovative approaches and tech solutions that have improved women's health outcomes
• Scaling up for impact - collaboration, partnerships, and sustainable funding models
• Looking to the future - What else can we do as an industry to close the gaps and create a more equitable future for women’s health